L
Loredana Miglietta
Researcher at University of Genoa
Publications - 39
Citations - 513
Loredana Miglietta is an academic researcher from University of Genoa. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 13, co-authored 39 publications receiving 454 citations.
Papers
More filters
Journal ArticleDOI
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.
Matteo Lambertini,Valeria Fontana,Claudia Massarotti,Francesca Poggio,Chiara Dellepiane,G. Iacono,A. Abate,Loredana Miglietta,Chiara Ferreccio,Maria Carolina Pescio,Benedetta Conte,Eva Blondeaux,Claudia Bighin,Alessia D'Alonzo,M. Vaglica,Elisa Zanardi,Francesco Boccardo,Alberto Ballestrero,Paola Anserini,Lucia Del Mastro +19 more
TL;DR: Despite the majority of young breast cancer patients are concerned about the risk of treatment-induced premature ovarian insufficiency and/or infertility, only a limited number of them required to access the fertility unit to undergo cryopreservation strategies.
Journal ArticleDOI
Carboplatin in advanced hormone refractory prostatic cancer patients
Luciano Canobbio,Domenico Guarneri,Loredana Miglietta,Andrea Decensi,F. Oneto,Francesco Boccardo +5 more
TL;DR: The results suggest that carboplatin possesses a moderate but definite activity in prostate cancer patients, and was manageable even in elderly patients with extensive bone metastases.
Journal ArticleDOI
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study
Benedetta Conte,Alessandra Fabi,Francesca Poggio,Eva Blondeaux,Chiara Dellepiane,Alessia D'Alonzo,Giuseppe Buono,Grazia Arpino,Valentina Magri,Giuseppe Naso,Daniele Presti,Silvia Mura,Andrea Fontana,Francesco Cognetti,Chiara Molinelli,S. Pastorino,Claudia Bighin,Loredana Miglietta,Francesco Boccardo,Matteo Lambertini,Lucia Del Mastro +20 more
TL;DR: The results show meaningful activity of T-DM1 after front-line pertuzumab plus trastuzumAB and a taxane, with about 27% of patients having an objective response and 40% of Patients achieving durable disease control.
Journal Article
Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: clinical activity and effect on insulin-like growth factor-I (IGF-I) levels.
TL;DR: The high remission rate reported, the absence of overlapping side effects between tamoxifen and somatuline and the synergistic activity on IGF-I suppression justify a further evaluation of the drug-combination.
Journal ArticleDOI
Cardioprotective effect of dexrazoxane in patients with breast cancer treated with anthracyclines in adjuvant setting: a 10-year single institution experience.
F. Testore,Simona Milanese,Marco Ceste,Enrico de Conciliis,Giuseppe Parello,Claudio Lanfranco,Roberto Manfredi,Gianfranco Ferrero,Carlotta Simoni,Loredana Miglietta,Silvia Ferro,Lorena Giaretto,Giuseppina Bosso +12 more
TL;DR: In this article, the authors analyzed the incidence of cardiac dysfunction over a 10-year period in patients with breast cancer who were treated with anthracycline-based regimens with addition of dexrazoxane, mainly in an adjuvant setting.